Physician profile
Zuleikha E Tyebjee
NPI 1104351493
$1,204.06
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $428 · 2022: $299 · 2023: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $204.05 | 2020-2023 | Mounjaro |
| Novo Nordisk INC | $138.33 | 2020-2023 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.73 | 2021-2023 | Jardiance |
| Gilead Sciences, INC. | $112.82 | 2021-2023 | |
| Viiv Healthcare Company | $96.67 | 2021-2023 | Apretude |
| Merck Sharp & Dohme LLC | $86.61 | 2021-2023 | Dificid, Delstrigo |
| Pfizer INC. | $77.39 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.49 | 2020-2023 | Xifaxan |
| Abbvie INC. | $34.11 | 2021 | |
| Inspire Medical Systems, INC. | $32.94 | 2023 | Inspire |
| Glaxosmithkline, LLC. | $29.19 | 2020-2023 | Arexvy, Shingrix |
| Janssen Pharmaceuticals, INC | $24.42 | 2023 | Spravato |
| Emd Serono, INC. | $21.90 | 2022 | |
| Hikma Pharmaceuticals USA | $21.37 | 2020 | |
| Amgen INC. | $19.16 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.24 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $18.17 | 2023 | Rexulti |
| Supernus Pharmaceuticals, INC. | $17.40 | 2023 | Qelbree |
| Eisai INC. | $17.12 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.67 | 2022 | |
| Exact Sciences Corporation | $15.51 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $14.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zuleikha Tyebjee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.